Back
Day Range
$29.64
$30.42
52-Week Range
$28.29
$43.18
Volume
479,129
50D / 200D Avg
$34.28
/
$35.10
Prev Close
$29.18
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -129.6 | 0.4 |
| P/B | 3.0 | 2.9 |
| ROE % | -2.4 | 3.7 |
| Net Margin % | -2.1 | 3.8 |
| Rev Growth 5Y % | 18.2 | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Revenue grew 18.15% annually over 5 years — strong growth
Debt/Equity of 0.18 — conservative balance sheet
Generating 48.28M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.27%
Capital efficient — spends only 1.69% of revenue on capex
Growth
Revenue Growth (5Y)
18.15%
Revenue (1Y)14.88%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-2.40%
ROIC-0.45%
Net Margin-2.14%
Op. Margin-0.64%
Safety
Debt / Equity
0.18
Current Ratio3.96
Interest Coverage-0.59
Valuation
P/E Ratio
-129.57
P/B Ratio3.02
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.88% | Revenue Growth (3Y) | 15.71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18.15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 534.53M | Net Income (TTM) | -11.45M |
| ROE | -2.40% | ROA | -1.75% |
| Gross Margin | 74.41% | Operating Margin | -0.64% |
| Net Margin | -2.14% | Free Cash Flow (TTM) | 48.28M |
| ROIC | -0.45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.18 | Current Ratio | 3.96 |
| Interest Coverage | -0.59 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -129.57 | P/B Ratio | 3.02 |
| P/S Ratio | 2.78 | PEG Ratio | 2.21 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.48B | Enterprise Value | 1.40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 534.53M | 465.31M | 399.25M | 330.38M | 274.33M |
| Net Income | -11.45M | -44.70M | -30.44M | -46.47M | 50.20M |
| EPS (Diluted) | -0.24 | -0.95 | -0.66 | -1.02 | 1.09 |
| Gross Profit | 397.74M | 347.52M | 300.37M | 245.94M | 205.86M |
| Operating Income | -3.45M | -40.01M | -26.68M | -42.67M | 55.21M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 654.18M | 609.33M | 613.93M | 585.45M | 615.31M |
| Total Liabilities | 162.24M | 148.36M | 147.76M | 128.69M | 131.56M |
| Shareholders' Equity | 491.94M | 460.97M | 466.17M | 456.75M | 483.76M |
| Total Debt | 88.02M | 76.53M | 74.49M | 74.55M | 75.65M |
| Cash & Equivalents | 167.43M | 122.72M | 84.31M | 58.10M | 43.65M |
| Current Assets | 322.52M | 267.83M | 266.25M | 215.21M | 196.08M |
| Current Liabilities | 81.52M | 73.42M | 74.57M | 58.39M | 56.45M |